Ultrasound features as predictive markers of BRAFV600E mutation in thyroid cancer: a systematic review and meta-analysis

被引:0
作者
Liu, Rongwei [1 ,2 ]
Li, Haiyuan [1 ]
Bai, Xiumei [1 ]
Yang, Hong [1 ]
He, Yun [1 ]
机构
[1] Guangxi Med Univ, Affiliated Hosp 1, Dept Med Ultrasound, 6 Shuangyong Rd, Nanning 530021, Peoples R China
[2] Gannan Med Univ, Affiliated Hosp 1, Dept Med Ultrasound, Ganzhou, Peoples R China
关键词
Thyroid cancer; ultrasound features; BRAFV600E; meta-analysis; BRAF MUTATION; CARCINOMA;
D O I
10.21037/gs-24-134
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background: Conflicting evidence exists on the predictive value of ultrasound characteristics for BRAFV600E gene expression in thyroid cancer. This study aimed to determine the predictive value of ultrasound features for BRAFV600E gene expression status in thyroid cancer. Methods: A systematic review of studies published before December 31, 2023, was conducted in the PubMed, Web of Science, and Cochrane Library databases. Studies evaluating the ultrasonographic features for predicting BRAFV600E gene mutations in thyroid cancer were included. The relevant data were extracted, and the quality of eligible studies was independently assessed by two reviewers. Statistical analysis was performed using RevMan 5.4 and Stata 12.0 software. Results: The meta-analysis included 13 studies involving a total of 2,250 thyroid cancer patients. Ultrasound features significantly associated with BRAFV600E gene expression status in thyroid cancer (P<0.05) comprised hypoechogenicity, absence of halo, irregular borders, and vertical orientation. Contrastingly, no significant differences were observed in solid composition, irregular shape, and microcalcifications (P>0.05). Among the seven ultrasound features, the ones with superior combined sensitivity for nodules were hypoechogenicity, solid composition, absence of halo, and irregular borders, with sensitivities of 0.93 [95% confidence interval (CI): 0.87-0.96], 0.93 (95% CI: 0.86-0.97), 0.83 (95% CI: 0.72-0.91), and 0.74 (95% CI: 0.64-0.83), respectively. Finally, the areas under the summary receiver operating characteristic (SROC) curve with the highest diagnostic performance were the absence of halo and hypoechogenicity, with area under the curve (AUC) of 0.84 (95% CI: 0.80-0.87) and 0.81 (95% CI: 0.77- 0.84), respectively. Conclusions: The expression status of the BRAFV600E gene in thyroid cancer correlates with nodules exhibiting hypoechogenicity, absence of halo, irregular borders, and taller-than-wide shape. Notably, the absence of a halo and hypoechogenicity were identified as the most predictive ultrasonic features. However, due to the limited sample size, there may be bias in the meta-analysis results, and more extensive research is necessary.
引用
收藏
页码:1243 / 1253
页数:14
相关论文
共 50 条
  • [41] DUAL PRIMING OLIGONUCLEOTIDE-BASED MULTIPLEX PCR ANALYSIS FOR DETECTION OF BRAFV600E MUTATION IN FNAB SAMPLES OF THYROID NODULES IN BRAFV600E MUTATION-PREVALENT AREA
    Kwak, Jin Young
    Kim, Eun-Kyung
    Kim, Jong-Kee
    Han, Jeong-Hyun
    Hong, Soon Won
    Park, Tae Sung
    Choi, Jong Rak
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2010, 32 (04): : 490 - 498
  • [42] BRAFV600E Mutation is Associated with an Increased Risk of Papillary Thyroid Cancer Recurrence
    Enumah, Samuel
    Fingeret, Abbey
    Parangi, Sareh
    Dias-Santagata, Dora
    Sadow, Peter M.
    Lubitz, Carrie C.
    WORLD JOURNAL OF SURGERY, 2020, 44 (08) : 2685 - 2691
  • [43] BRAFV600E mutation is associated with aggressive features in papillary thyroid carcinomas ≤ 1.5 cm
    Jennifer A. Silver
    Mariya Bogatchenko
    Marc Pusztaszeri
    Véronique-Isabelle Forest
    Michael P. Hier
    Ji Wei Yang
    Michael Tamilia
    Richard J. Payne
    Journal of Otolaryngology - Head & Neck Surgery, 50
  • [44] Diagnostic value of BRAFV600E-mutation analysis in fine-needle aspiration of thyroid nodules: a meta-analysis
    Su, Xingyun
    Jiang, Xiaoxia
    Xu, Xin
    Wang, Weibin
    Teng, Xiaodong
    Shao, Anwen
    Teng, Lisong
    ONCOTARGETS AND THERAPY, 2016, 9 : 2495 - 2509
  • [45] Clinical implication of the BRAFV600E mutation in papillary thyroid carcinoma
    Kim, Yong-Seok
    Kim, Jeong-Soo
    Bae, Ja-Seong
    Park, Woo-Chan
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2013, 11
  • [46] Aberrant hypermethylation of the HOXD10 gene in papillary thyroid cancer with BRAFV600E mutation
    Cao, Yi-Ming
    Gu, Jun
    Zhang, Yan-Shu
    Wei, Wen-Jun
    Qu, Ning
    Wen, Duo
    Liao, Tian
    Shi, Rong-Liang
    Zhang, Ling
    Ji, Qing-Hai
    Wang, Yu
    Sun, Guo-Hua
    Zhao, Yang-Xing
    Wang, Yuan-Jin
    Yu, Jian
    Zhu, Yong-Xue
    ONCOLOGY REPORTS, 2018, 39 (01) : 338 - 348
  • [47] BRAFV600E Mutation Analysis in Papillary Thyroid Carcinoma: Is it Useful for all Patients?
    Ito, Yasuhiro
    Yoshida, Hiroshi
    Kihara, Minoru
    Kobayashi, Kaoru
    Miya, Akihiro
    Miyauchi, Akira
    WORLD JOURNAL OF SURGERY, 2014, 38 (03) : 679 - 687
  • [48] Preoperative BRAFV600E mutation detection in thyroid carcinoma by immunocytochemistry
    Swan, Kristine Zoylner
    Madsen, Stine Horskaer
    Bonnema, Steen Joop
    Nielsen, Viveque Egsgaard
    Jespersen, Marie Louise
    APMIS, 2022, 130 (11) : 627 - 636
  • [49] Clinical implication of the BRAFV600E mutation in papillary thyroid carcinoma
    Yong-Seok Kim
    Jeong-Soo Kim
    Ja-Seong Bae
    Woo-Chan Park
    World Journal of Surgical Oncology, 11
  • [50] Pyrosequencing analysis for detection of a BRAFV600E mutation in an FNAB specimen of thyroid nodules
    Kim, Suk Kyeong
    Kim, Dong-Lim
    Han, Hye Seung
    Kim, Wan Seop
    Kim, Seung Ja
    Moon, Won Jin
    Oh, Seo Young
    Hwang, Tae Sook
    DIAGNOSTIC MOLECULAR PATHOLOGY, 2008, 17 (02) : 118 - 125